Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Where Are Teva Shares Headed After the Q4 Decline?
Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray
News of Charges in Price-Fixing Inquiry Sends Pharmaceuticals Tumbling - The New York Times
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) Agrees To Settle With The SEC Over Corruption Charges - Market Exclusive
Teva Retests Lows After Judge Declines Settlement Offer
Teva Breaks Out Amid Hopes of Global Opioid Settlement
TEVA Stock Price and Chart — TASE:TEVA — TradingView
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha